Cookie Settings
 
This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here.
This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here.

Counselling tips for your consultations with women
considering NEXPLANON®

Initially, it is important that the woman visiting your clinic is made to feel comfortable discussing contraception during the consultation,2 with her partner present if she chooses.

Communicate clearly using day-to-day language that women can relate to. For example, when communicating the effectiveness* of NEXPLANON®, instead of “over 99%”,1,3 this could be expressed as “less than 1 in 100 typical users of implants become pregnant”.1,3

*Safety and efficacy have been established in women between 18 and 40 years of age.1

LARC: long-acting reversible contraceptive

References

  1. NEXPLANON® Summary of Product Characteristics
  2. Faculty of Sexual & Reproductive Healthcare. Service standards for consultations in sexual and reproductive health services, June 2020. Available at: https://www.fsrh.org/standards-and-guidance/documents/fsrh-service-standards-for-consultations-june-2020/. Accessed September 2021
  3. Faculty of Sexual & Reproductive Healthcare. Clinical guideline: progestogen-only implant, February 2021. Available at: https://www.fsrh.org/documents/cec-ceu-guidance-implants-feb-2014/. Accessed September 2021
  4. Mansour D et al. The effects of IMPLANON® on menstrual bleeding patterns. Eur J Contracept Reprod Health Care 2008;13 Suppl 1:13-28
  5. Faculty of Sexual & Reproductive Healthcare. Clinical guideline: problematic bleeding with hormonal contraception, September 2015. Available at: https://www.fsrh.org/documents/ceuguidanceproblematicbleedinghormonalcontraception/. Accessed September 2021
  6. Mansour D. Contraception 2018 - a counselling master class. A webinar hosted by MSD. 5 June 2018

GB-XPL-115003 | Date of preparation: September 2021

GB-XPL-115074 | Date of preparation: September 2021